참고문헌 (27)

1. 1 Myllykangas-Luosujarvi RA Aho K Isomaki HA Mortality in rheumatoid arthritis Semin Arthritis Rheum 1995 25 3 193 202 8650589 

   상세보기

2. 2 Kung M Stork S Angermann CE Cardiovascular comorbidity in rheumatic disease. Does sex play a role? Herz 2005 30 6 512 21 16170682 

3. 3 Trelle S Reichenbach S Wandel S Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis BMJ 2011 342 c7086 21224324 

   상세보기

4. 4 Simon LS Mills JA Drug therapy: nonsteroidal antiinflammatory drugs (first of two parts) N Engl J Med 1980 302 21 1179 85 6988717 

   상세보기

5. 5 Gotzsche PC Johansen HK Meta-analysis of short-term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis BMJ 1998 316 7134 811 8 9549450 

6. 6 Landewe RB Boers M Verhoeven AC COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention Arthritis Rheum 2002 46 2 347 56 11840436 

7. 7 Courtney P Doherty M Joint aspiration and injection Best Pract Res Clin Rheumatol 2005 19 3 345 69 15939363 

8. 8 Katchamart W Trudeau J Phumethum V Bombardier C Efficacy and toxicity of methotrexate (MTX) monotherapy versus MTX combination therapy with non-biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and meta-analysis Ann Rheum Dis 2009 68 7 1105 12 19054823 

9. 9 Jansen G van der Heijden J Oerlemans R Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis Arthritis Rheum 2004 50 7 2130 9 15248210 

10. 10 Smolen JS Kalden JR Scott DL Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. European Leflunomide Study Group Lancet 23 1999 353 9149 259 66 9929017 

11. 11 Emery P Breedveld FC Lemmel EM A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis Rheumatology 2000 39 6 655 65 10888712 

12. 12 Bongartz T Sutton AJ Sweeting MJ Buchan I Matteson EL Montori V Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials JAMA 17 2006 295 19 2275 85 16705109 

13. 13 Simard JF Neovius M Askling J Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register Arthritis Rheum 2012 64 11 3502 10 22886739 

14. 14 Klareskog L van der Heijde D de Jager JP Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial Lancet 28 2004 363 9410 675 81 15001324 

15. 15 Keystone EC Kavanaugh AF Sharp JT Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial Arthritis Rheum 2004 50 5 1400 11 15146409 

16. 16 Breedveld FC Weisman MH Kavanaugh AF The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment Arthritis Rheum 2006 54 1 26 37 16385520 

17. 17 Maini R St Clair EW Breedveld F Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group Lancet 1999 354 9194 1932 9 10622295 

18. 18 Maini RN Breedveld FC Kalden JR Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate Arthritis Rheum 2004 50 4 1051 65 15077287 

19. 19 Keystone E Heijde D Mason D Jr Certolizumab pegol plus methotrexate is significantly more effective than placebo plus methotrexate in active rheumatoid arthritis: findings of a fifty-two-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study Arthritis Rheum 2008 58 11 3319 29 18975346 

20. 20 Keystone EC Genovese MC Klareskog L Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD Study Ann Rheum Dis 2009 68 6 789 96 19066176 

21. 21 Edwards JC Szczepanski L Szechinski J Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis N Engl J Med 2004 350 25 2572 81 15201414 

    상세보기

22. 22 Cohen SB Emery P Greenwald MW Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks Arthritis Rheum 2006 54 9 2793 806 16947627 

23. 23 Molloy ES Calabrese LH Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies Arthritis Rheum 2012 64 9 3043 51 22422012 

24. 24 Hazlewood GS Barnabe C Barr SG Martin L Abatacept use after failure of multiple biologic agents in patients with severe rheumatoid arthritis J Clin Rheumatol 2012 18 8 416 8 23188208 

    상세보기

25. 25 Gabay C Emery P van Vollenhoven R Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial Lancet 2013 381 9877 1541 50 23515142 

26. 26 Cohen S Hurd E Cush J Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial Arthritis Rheum 2002 46 3 614 24 11920396 

27. 27 Zerbini CA Lomonte AB Tofacitinib for the treatment of rheumatoid arthritis Expert Rev Clin Immunol 2012 8 4 319 31 22607178